Latest
Find the latest updates, upcoming scientific events, and curated resources to stay connected with ongoing research and collaboration opportunities.
Publications
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer
Original Investigation
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial
Article
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
Article
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial
Article
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
ASCO Educational Book
Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy
Pharmacomicrobiomics Review
White Paper: Can Antibiotics undermine Cancer Immunotherapy Outcomes?
Coming Later 2025
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Derosa 2018
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Elkrief 2024
Upcoming Events
ASCO Annual Meeting 2026
29 May-2 June 2026
Chicago, USA
The upcoming ASCO Annual Meeting will bring together clinicians, researchers, and industry leaders from around the world to share cutting-edge discoveries, foster collaboration, and drive the next wave of innovation in cancer care.
ESMO Congress 2026
23-27 October 2026
Madrid, Spain
The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
Annual Steering Committee Meeting 2026
16-18 November 2026
Zürich, Switzerland
The Consortium is gathering to exchange the latest findings, align on vision & strategy, and strengthen the partnerships driving one of the most ambitious efforts in cancer microbiome research. A further purpose of the meeting will be to build a strategy for the next phase.
Previous Events
ESMO Congress 2025
17-21 October 2025
Berlin, Germany
The ESMO Congress 2025 brought together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world as a leading global oncology platform.
ASCO Annual Meeting 2025
30 May-03 June 2025
Chicago, USA
Held in Chicago, the 2025 ASCO Annual Meeting convened tens of thousands of oncology professionals to share over 7,000 abstracts, showcasing new therapies, emerging treatment strategies, and progress in cancer care worldwide.
PIO Annual Meeting 2025
16-17 June 2025
Paris, France
The 2025 Paris Immuno-Oncology Conference (PIO) focused on tumor immunology, immunotherapy, and the microbiota–immune interface, exploring the links between cancer, immunity, and the microbiota while advancing innovative therapeutic strategies.
Resources
TOPOSCORE Calculator
A calculator that generates a Toposcore from microbiome data and positions samples across survival-associated reference groups.
TOPOSCORE
A proxy for gut dysbiosis calculated using species-interacting groups (SIGs) that correlate with overall survival.